Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Irbesartan MeSH Descriptor Data 2026


MeSH Heading
Irbesartan
Tree Number(s)
D02.455.426.559.389.185.413
D02.455.426.779.431
D03.383.129.617.351
D04.711.431
Unique ID
D000077405
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077405
Scope Note
A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
Entry Term(s)
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
Aprovel
Avapro
BMS 186295
BMS-186295
Karvea
SR 47436
SR-47436
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
J0E2756Z7N
0
Related Numbers
138402-11-6
CAS Type 1 Name
1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
Public MeSH Note
2019; IRBESARTAN was indexed under BIPHENYL COMPOUNDS and TETRAZOLES 1993-2018
History Note
2019 (1993)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Irbesartan Preferred
SR 47436 Narrower
BMS 186295 Narrower
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one Related
Aprovel Narrower
Karvea Narrower
Avapro Narrower
page delivered in 0.128s